ArticleFrontiers in immunology2023

The impact of EMA recommendations on the real-life use of Janus kinases inhibitors for rheumatoid arthritis: the Expanded Risk Score in RA as a tool to quantify the risk of cardiovascular events.

Ennio Giulio Favalli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.